The table below shows 4D Molecular Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$85.21M
$37.00K
$20.72M
$3.13M
$18.04M
$13.61M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$49.06M
FDMT annual revenue (10-K history)
4D Molecular Therapeutics, Inc. reported annual revenue of $85.21M for fiscal year 2025. That is up 230194.6% from $37.00K in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $6.99M (FY 2019) to $85.21M. Figures come from the company's audited annual reports as filed with the SEC.